Candidate Drug 80/5Technology Demonstration4 (Anti-dyslipidemic)
Implementing Organization
Central Drug Research Institute (CDRI)
Project Overview
Anti-Dyslipidemic drug especially used in Dyslipidemia of Diabetes, Metabolic syndrome Obesity
For managing patients of hyperlipidemia especially triglycerides and cholesterol